These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 24858152

  • 21. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 22. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment.
    Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K, Japanese Study Group of Kidney Disease in Children.
    Kidney Int; 2015 Jan 10; 87(1):225-32. PubMed ID: 25054775
    [Abstract] [Full Text] [Related]

  • 23. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K, Parikh A, Webb H, Hothi D.
    Pediatr Nephrol; 2017 Jan 10; 32(1):99-105. PubMed ID: 27677978
    [Abstract] [Full Text] [Related]

  • 24. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
    Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
    [Abstract] [Full Text] [Related]

  • 25. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
    Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
    Nihon Jinzo Gakkai Shi; 1998 Nov 27; 40(8):587-90. PubMed ID: 9893457
    [Abstract] [Full Text] [Related]

  • 26. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
    [Abstract] [Full Text] [Related]

  • 27. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK, Bagga A, Srivastava RN.
    Pediatr Nephrol; 1997 Oct 20; 11(5):597-9. PubMed ID: 9323286
    [Abstract] [Full Text] [Related]

  • 28. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
    Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
    Am J Kidney Dis; 1998 Jun 20; 31(6):932-9. PubMed ID: 9631836
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
    Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
    Clin Exp Nephrol; 2020 Jul 20; 24(7):622-629. PubMed ID: 32201918
    [Abstract] [Full Text] [Related]

  • 30. Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
    Weerasooriya WALK, Abeyagunawardena AS, Thalgahagoda RS.
    Eur J Pediatr; 2023 Apr 20; 182(4):1741-1747. PubMed ID: 36757496
    [Abstract] [Full Text] [Related]

  • 31. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
    Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF.
    BMJ Open; 2017 Sep 27; 7(9):e018148. PubMed ID: 28963315
    [Abstract] [Full Text] [Related]

  • 32. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan 27; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 33. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
    Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
    [Abstract] [Full Text] [Related]

  • 34. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 04; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 35. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 04; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 36. [Glucocorticoid therapy for children with idiopathic nephrotic syndrome].
    Kadowaki J.
    Hokkaido Igaku Zasshi; 1994 May 04; 69(3):403-10. PubMed ID: 7927169
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 04; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 38. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.
    Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WC, Wetzels JF, van der Heijden AJ, Nauta J.
    J Am Soc Nephrol; 2013 Jan 04; 24(1):149-59. PubMed ID: 23274956
    [Abstract] [Full Text] [Related]

  • 39. Treating the idiopathic nephrotic syndrome: are steroids the answer?
    Deschênes G, Dossier C, Hogan J.
    Pediatr Nephrol; 2019 May 04; 34(5):777-785. PubMed ID: 29869116
    [Abstract] [Full Text] [Related]

  • 40. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr 04; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.